Leonhardt S, Gorospe E, Hoffman B J, Teitler M
Department of Pharmacology and Toxicology, Albany Medical Center, New York 12208.
Mol Pharmacol. 1992 Aug;42(2):328-35.
5-Hydroxytryptamine (5HT)1C and 5HT2 receptors appear to be closely related, from a molecular viewpoint, displaying similar second messenger systems and a high degree of sequence homology. However, there are striking differences in the interactions of 5HT with 5HT1C and 5HT2 receptors; 5HT is generally more potent in stimulating responses mediated through 5HT1C receptors than responses mediated through 5HT2 receptors. Also [3H]5HT labels 5HT1C receptors and not 5HT2 receptors. In order to explore more fully the molecular rationale for these differences, radioligand binding studies were performed in rat, human, and porcine brain and choroid plexus tissues and in mammalian cells transfected with rat 5HT1C or 5HT2 receptors; second messenger studies (inositol phosphate accumulation) were performed in the transfected cells. The second messenger studies confirmed the approximately 10-fold higher potency of 5HT in stimulating intracellular responses through 5HT1C receptors (EC50 = 8.3 nM) than in stimulating intracellular responses through 5HT2 receptors (EC50 = 101 nM). An agonist radioligand selective for the 5HT1C and 5HT2 receptors, 2,5-dimethoxy-(4-[125I]iodo)phenylisopropylamine, was used, as well as [3H]5HT, [3H]mesulergine (antagonist radioligand for 5HT1C receptors), and [3H]ketanserin (antagonist radioligand for 5HT2 receptors). Computer-assisted analyses of the binding data revealed two agonist affinity states for the 5HT1C receptor. The agonist high affinity state of the receptor was modifiable by guanyl nucleotides. The proportion of agonist high affinity states, relative to the total receptor population, was approximately 10% for both receptors. The apparent higher affinity of 5HT for the radiolabeled 5HT1C receptors was due to the higher affinity 5HT displayed for the agonist low affinity state of the 5HT1C receptor, compared with the affinity of 5HT for the agonist low affinity state of the 5HT2 receptor. The correspondence between the higher affinity of 5HT for the agonist low affinity state of the 5HT1C receptor, relative to the 5HT2 receptor, and the higher potency of 5HT in stimulating 5HT1C responses indicates that 5HT interacts with the agonist low affinity state of the 5HT1C and 5HT2 receptors in initiating its biological effects. These observations indicate that guanine nucleotide-binding protein (G protein)-coupled receptors can exhibit high affinity for neurotransmitters in both the free receptor and the G protein-coupled states and that receptors exhibiting this property may represent a novel subfamily of G protein-coupled receptors.
从分子角度来看,5-羟色胺(5HT)1C和5HT2受体似乎密切相关,表现出相似的第二信使系统和高度的序列同源性。然而,5HT与5HT1C和5HT2受体的相互作用存在显著差异;一般而言,5HT刺激通过5HT1C受体介导的反应比刺激通过5HT2受体介导的反应更有效。此外,[3H]5HT标记5HT1C受体而非5HT2受体。为了更全面地探究这些差异的分子原理,在大鼠、人类和猪的脑及脉络丛组织以及转染了大鼠5HT1C或5HT2受体的哺乳动物细胞中进行了放射性配体结合研究;在转染细胞中进行了第二信使研究(肌醇磷酸积累)。第二信使研究证实,5HT刺激通过5HT1C受体的细胞内反应(EC50 = 8.3 nM)的效力比刺激通过5HT2受体的细胞内反应(EC50 = 101 nM)高约10倍。使用了对5HT1C和5HT2受体具有选择性的激动剂放射性配体2,5-二甲氧基-(4-[125I]碘)苯异丙胺,以及[3H]5HT、[3H]美舒麦角林(5HT1C受体的拮抗剂放射性配体)和[3H]酮色林(5HT2受体的拮抗剂放射性配体)。对结合数据的计算机辅助分析揭示了5HT1C受体的两种激动剂亲和状态。受体的激动剂高亲和状态可被鸟苷酸修饰。两种受体的激动剂高亲和状态相对于总受体群体的比例约为10%。5HT对放射性标记的5HT1C受体的明显更高亲和力是由于与5HT对5HT2受体激动剂低亲和状态的亲和力相比,5HT对5HT1C受体激动剂低亲和状态显示出更高的亲和力。5HT对5HT1C受体激动剂低亲和状态相对于5HT2受体的更高亲和力与5HT刺激5HT1C反应的更高效力之间的对应关系表明,5HT在启动其生物学效应时与5HT1C和5HT2受体的激动剂低亲和状态相互作用。这些观察结果表明,鸟嘌呤核苷酸结合蛋白(G蛋白)偶联受体在游离受体和G蛋白偶联状态下都可对神经递质表现出高亲和力,并且表现出这种特性的受体可能代表G蛋白偶联受体的一个新亚家族。